QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.105.085449v1 316/1/1    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Farhadi, A. Articles by Banan, A. Search for Related Content PubMed PubMed Citation Articles by Farhadi, A. Articles by Banan, A. Pubmed/NCBI databases Domain Substance via MeSH

PERSPECTIVES IN PHARMACOLOGY

The Role of Protein Kinase C Isoforms in Modulating Injury and Repair of the Intestinal Barrier

Section of Gastroenterology and Nutrition, Rush University Medical Center, Chicago, Illinois

Gastrointestinal cells express a diverse group of protein kinase C (PKC) isoforms that play critical roles in a number of cell functions, including intracellular signaling and barrier integrity. PKC isoforms expressed by gastrointestinal epithelial cells consist of three major PKC subfamilies: conventional isoforms (, 1, 2, and ), novel isoforms (, , , , and µ), and atypical isoforms (, , and ). This review highlights recent discoveries, including our own, that some PKC isoforms in gastrointestinal epithelia monolayer cell culture are involved in injury to, whereas others are involved in protection of, intestinal barrier integrity. For example, certain PKC isoforms aggravate oxidative damage, whereas others protect against it. These findings suggest that the development of agents that selectively activate or inhibit specific PKC isoforms may lead to new therapeutic modalities for important gastrointestinal disorders such as cancer and inflammatory bowel disease.

Address correspondence to: Dr. Ashkan Farhadi, Rush University Medical Center, Division of Digestive Diseases, 1725 W. Harrison, Suite 206, Chicago, IL 60612. E-mail: ashkan_farhadi{at}rush.edu

This article has been cited by other articles:

				V. A. Swystun, B. Renaux, F. Moreau, S. Wen, M. A. Peplowski, M. D. Hollenberg, and W. K. MacNaughton Serine proteases decrease intestinal epithelial ion permeability by activation of protein kinase C{zeta} Am J Physiol Gastrointest Liver Physiol, July 1, 2009; 297(1): G60 - G70. [Abstract] [Full Text] [PDF]

				T. P. Abeyweera, X. Chen, and S. A. Rotenberg Phosphorylation of {alpha}6-Tubulin by Protein Kinase C{alpha} Activates Motility of Human Breast Cells J. Biol. Chem., June 26, 2009; 284(26): 17648 - 17656. [Abstract] [Full Text] [PDF]

				J. Q. van der Merwe, F. Moreau, and W. K. MacNaughton Protease-activated receptor-2 stimulates intestinal epithelial chloride transport through activation of PLC and selective PKC isoforms Am J Physiol Gastrointest Liver Physiol, June 1, 2009; 296(6): G1258 - G1266. [Abstract] [Full Text] [PDF]

				A. Seth, F. Yan, D. B. Polk, and R. K. Rao Probiotics ameliorate the hydrogen peroxide-induced epithelial barrier disruption by a PKC- and MAP kinase-dependent mechanism Am J Physiol Gastrointest Liver Physiol, April 1, 2008; 294(4): G1060 - G1069. [Abstract] [Full Text] [PDF]

				J. Kanchanapoo, M. Ao, R. Prasad, C. Moore, C. Kay, P. Piyachaturawat, and M. C. Rao Role of protein kinase C-{delta} in the age-dependent secretagogue action of bile acids in mammalian colon Am J Physiol Cell Physiol, December 1, 2007; 293(6): C1851 - C1861. [Abstract] [Full Text] [PDF]

				B. R. Chaitman Ranolazine for the Treatment of Chronic Angina and Potential Use in Other Cardiovascular Conditions Circulation, May 23, 2006; 113(20): 2462 - 2472. [Full Text] [PDF]